Gray William Garrett's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Feb 2, 2022
- Accession no.
- 0001104659-22-010998
- Filed
- Feb 2, 2022
- Trade date
- Jan 31-Feb 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $93.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gray William GarrettCIK 0001692961 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | COMMON STOCK (RESTRICTED) | AGrant or awardAcquired | +137,000 | $0.00 | $0 | 619,170 | Direct | |
| Feb 1, 2022 | COMMON STOCK | SSaleDisposed | −37,063 | $2.51F4 | −$93,028.13 | 582,107 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.50 to $2.55. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.